TLR3 and neoplasm: Furthermore, poly (I:C) can mediate tumor cell apoptosis and activate NK cells 42,43 Currently, TLR3 ligands are being tested either alone or in combination with chemotherapeutics or immunotherapeutics in several cancer immunotherapy trials.